Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001178913-23-003250
Filing Date
2023-09-29
Accepted
2023-09-29 06:10:53
Documents
1
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 6463
  Complete submission text file 0001178913-23-003250.txt   9277
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 OPPENHEIMER ST. REHOVOT L3 7670104
Business Address 4 OPPENHEIMER ST. REHOVOT L3 7670104 972-722-514-175
Israel Biotech Fund I, L.P. (Reporting) CIK: 0001652458 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-36138 | Film No.: 231291681

Mailing Address 4 OPPENHEIMER ST. REHOVOT L3 7670104
Business Address 4 OPPENHEIMER ST. REHOVOT L3 7670104 011-972-722-514-175
I.B.F. Management Ltd. (Reporting) CIK: 0001994849 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-36138 | Film No.: 231291679

Mailing Address 4 OPPENHEIMER ST. REHOVOT L3 7670104
Business Address 4 OPPENHEIMER ST. REHOVOT L3 7670104 011-972-722-514-175
Israel Biotech Fund GP Partners, L.P. (Reporting) CIK: 0001994922 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-36138 | Film No.: 231291680